Terms: = Lymphoma AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1
10 results:
1. Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden.
Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.
Ashraf U; Ding Z; Deng S; Ye J; Cao S; Chen Z
Virulence; 2021 Dec; 12(1):968-980. PubMed ID: 33724154
[TBL] [Abstract] [Full Text] [Related]
3. Activation of the c-Jun NH
Fung TS; Liu DX
Cell Death Dis; 2017 Dec; 8(12):3215. PubMed ID: 29238080
[TBL] [Abstract] [Full Text] [Related]
4. A novel synthetic analogue of ω-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells.
Dyari HRE; Rawling T; Chen Y; Sudarmana W; Bourget K; Dwyer JM; Allison SE; Murray M
FASEB J; 2017 Dec; 31(12):5246-5257. PubMed ID: 28798154
[TBL] [Abstract] [Full Text] [Related]
5. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.
Jones CL; Gearheart CM; Fosmire S; Delgado-Martin C; Evensen NA; Bride K; Waanders AJ; Pais F; Wang J; Bhatla T; Bitterman DS; de Rijk SR; Bourgeois W; Dandekar S; Park E; Burleson TM; Madhusoodhan PP; Teachey DT; Raetz EA; Hermiston ML; Müschen M; Loh ML; Hunger SP; Zhang J; Garabedian MJ; Porter CC; Carroll WL
Blood; 2015 Nov; 126(19):2202-12. PubMed ID: 26324703
[TBL] [Abstract] [Full Text] [Related]
6. Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
An J; Liu H; Magyar CE; Guo Y; Veena MS; Srivatsan ES; Huang J; Rettig MB
Cancer Res; 2013 Feb; 73(4):1374-85. PubMed ID: 23393199
[TBL] [Abstract] [Full Text] [Related]
7. [Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Ostański M; Sońta-Jakimczyk D
Wiad Lek; 2002; 55(3-4):164-73. PubMed ID: 12182001
[TBL] [Abstract] [Full Text] [Related]
8. Differential activation of the c-Jun N-terminal kinase pathway in arsenite-induced apoptosis and sensitization of chemically resistant compared to susceptible B-lymphoma cell lines.
Muscarella DE; Bloom SE
Toxicol Sci; 2002 Jul; 68(1):82-92. PubMed ID: 12075113
[TBL] [Abstract] [Full Text] [Related]
9. [Exercise tolerance in patients after acute lymphoblastic leukemia treatment in childhood].
Ostański M; Sońta-Jakimczyk D
Wiad Lek; 2001; 54(11-12):650-5. PubMed ID: 11928552
[TBL] [Abstract] [Full Text] [Related]
10. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC
EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303
[TBL] [Abstract] [Full Text] [Related]